When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images Central sleep apnea (CSA) is a sleep disorder that is less common than ...

The Food and Drug Administration has approved a GLP-1 agonist for treating sleep apnea. Here’s how it works and what you can ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage their type 2 diabetes. And as of December 20, Eli Lilly’s weight loss ...

Inspire Medical Systems, which produces an implant to treat sleep apnea, extended the run spots involving the Golden Bachelorette winner through the holidays.

Obstructive sleep apnea is a condition in which a blockage of airways by weak, heavy or relaxed soft tissues disrupts ...

Apnimed has announced The Lancet has published positive results from the Phase 2 FLOW study evaluating sulthiame, a differentiated, once-daily oral carbonic anhydrase inhibitor, in the treatment of ...

Rochester, Minn.-based Mayo Clinic has developed an AI algorithm that can detect obstructive sleep apnea using electrocardiogram results.

MARYSVILLE, OH – October 22, 2025 – PRESSADVANTAGE – Sleep Better Marysville, a dental practice specializing in sleep apnea ...

The link between OSA and headaches is well established. “Morning headaches have long been recognized as a marker for sleep apnea,” says Avram Gold, MD, director of the sleep medicine fellowship at the ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound, made by ...